Comparison of <sup>11</sup>C-Pittsburgh Compound B and <sup>18</sup>F-Flutemetamol White Matter Binding in PET.

Zeydan, Burcu; Schwarz, Christopher G; Przybelski, Scott A; Lesnick, Timothy G; Kremers, Walter K; Senjem, Matthew L; Kantarci, Orhun H; Min, Paul H et al. · J Nucl Med · 2022

Where this comes from

Abstract

PET imaging with β-amyloid ligands is emerging as a molecular imaging technique targeting white matter integrity and demyelination. β-amyloid PET ligands such as <sup>11</sup>C-Pittsburgh compound B (<sup>11</sup>C-PiB) have been considered for quantitative measurement of myelin content changes in multiple sclerosis, but <sup>11</sup>C-PiB is not commercially available given its short half-life. A <sup>18</sup>F PET ligand such as flutemetamol with a longer half-life may be an alternative, but its ability to differentiate white matter hyperintensities (WMH) from normal-appearing white matter (NAWM) and its relationship with age remains to be investigated. <b>Methods:</b> Cognitively unimpaired (CU) older and younger adults (<i>n</i> = 61) were recruited from the community responding to a study advertisement for β-amyloid PET. Participants prospectively underwent MRI, <sup>11</sup>C-PiB, and <sup>18</sup>F-flutemetamol PET scans. MRI fluid-attenuated inversion recovery images were segmented into WMH and NAWM and registered to the T1-weighted MRI. <sup>11</sup>C-PiB and <sup>18</sup>F-flutemetamol PET images were also registered to the T1-weighted MRI. <sup>11</sup>C-PiB and <sup>18</sup>F-flutemetamol SUV ratios (SUVrs) from the WMH and NAWM were calculated using cerebellar crus uptake as a reference for both <sup>11</sup>C-PiB and <sup>18</sup>F-flutemetamol. <b>Results:</b> The median age was 38 y (range, 30-48 y) in younger adults and 67 y (range, 61-83 y) in older adults. WMH and NAWM SUVrs were higher with <sup>18</sup>F-flutemetamol than with <sup>11</sup>C-PiB in both older (<i>P</i> < 0.001) and younger (<i>P</i> < 0.001) CU adults. <sup>11</sup>C-PiB and <sup>18</sup>F-flutemetamol SUVrs were higher in older than in younger CU adults in both WMH (<i>P</i> < 0.001) and NAWM (<i>P</i> < 0.001). <sup>11</sup>C-PiB and <sup>18</sup>F-flutemetamol SUVrs were higher in NAWM than WMH in both older (<i>P</i> < 0.001) and younger (<i>P</i> < 0.001) CU adults. There was no apparent difference between <sup>11</sup>C-PiB and <sup>18</sup>F-flutemetamol SUVrs in differentiating WMH from NAWM in older and in younger adults. <b>Conclusion:</b><sup>11</sup>C-PiB and <sup>18</sup>F-flutemetamol show a similar topographic pattern of uptake in white matter with a similar association with age in WMH and NAWM. <sup>11</sup>C-PiB and <sup>18</sup>F-flutemetamol can also effectively distinguish between WMH and NAWM. However, given its longer half-life, commercial availability, and higher binding potential, <sup>18</sup>F-flutemetamol can be an alternative to <sup>11</sup>C-PiB in molecular imaging studies specifically targeting multiple sclerosis to evaluate white matter integrity.

Medical subject headings